Related Experiment Video
Updated: Oct 18, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study
I C Westendorp1, B A in 't Veld, M L Bots
1Departments of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
Insights
Hormone replacement therapy (HRT) use for over one year was linked to reduced carotid artery intima-media thickness (IMT) in postmenopausal women. This suggests HRT may inhibit atherosclerosis, a key factor in cardiovascular disease.
Area of Science:
- Cardiovascular Health
- Endocrinology
- Gerontology
Background:
- Observational data indicate hormone replacement therapy (HRT) may reduce cardiovascular disease morbidity and mortality in postmenopausal women.
- Potential mechanisms include inhibition of the atherosclerotic process.
Purpose of the Study:
- To investigate the association between HRT use and intima-media thickness (IMT) of the common carotid artery.
- To explore the relationship between HRT duration and IMT in elderly women.
Main Methods:
- A population-based cohort study (Rotterdam Study) involving 1103 naturally menopausal women aged 55-80.
- Noninvasive B-mode ultrasound was used to measure mean and maximum IMT of the common carotid artery.
- Statistical analysis adjusted for age, smoking, educational level, blood pressure, and BMI.
Main Results:
- Ever use of HRT for >= 1 year was significantly associated with decreased mean IMT (0.719 mm vs. 0.742 mm, P=0.03) and maximum IMT (0.952 mm vs. 0.983 mm, P=0.04).
- No significant association was found for HRT use < 1 year.
- Adjustments for diabetes, healthcare visits, and cholesterol levels did not alter the findings.
Conclusions:
- Ever use of hormone replacement therapy is associated with reduced intima-media thickness in the common carotid artery of elderly women.
- This finding supports a potential role for HRT in mitigating atherosclerotic changes.
Background And Purpose:
Observational data suggest that hormone replacement therapy (HRT) reduces morbidity and mortality from cardiovascular disease in healthy postmenopausal women. The mechanisms underlying this protection are not entirely clear but may include inhibition of the atherosclerotic process.
Methods:
We studied the association between ever use of HRT and intima-media thickness (IMT) of the common carotid artery in 1103 naturally menopausal women, aged 55 to 80 years, in the Rotterdam Study, a community-based cohort study in a suburban area of Rotterdam, Netherlands. Mean and maximum IMT of the common carotid artery were measured noninvasively with B-mode ultrasound.
Results:
Ever use of HRT for >/=1 year was associated with a decreased mean and maximum IMT compared with never users (mean IMT, 0.719 mm [SE 0.01] versus 0. 742 mm [SE 0.004], P=0.03; maximum IMT, 0.952 mm [SE 0.015] versus 0. 983 mm [SE 0.006], P=0.04), after adjustment for age, smoking, educational level, systolic blood pressure, and body mass index. No association was found for use <1 year (mean IMT, 0.739 mm [SE 0.013] versus 0.742 mm [SE 0.004], P=0.69; maximum IMT, 0.990 mm [SE 0.019] versus 0.983 mm [SE 0.006], P=0.75). Additional adjustment for diabetes, frequency of visits to healthcare facilities, or total and HDL cholesterol did not change these results.
Conclusions:
The findings of this population-based study show that ever use of HRT is associated with a decreased IMT in the common carotid artery in elderly women.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease III: Interprofessional Care
